Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)
Francesco Panzuto, Marco Maccauro, Davide Campana, Antongiulio Faggiano, Sara Massironi, Sara Pusceddu, Francesca Spada, Diego Ferone, Roberta Modica, C.M. Grana, Piero Ferollà, Maria Rinzivillo, Giuseppe Badalamenti, Maria Chiara Zatelli, Fabio Gelsomino, Eugenio De Carlo, Mirco Bartolomei, Maria Pia Brizzi, Sara Cingarlini, Annibale Versari, Giuseppe Fanciulli, Emanuela Arvat, Elettra Merola, Mauro Cives, Salvatore Tafuto, Sergio Baldari, Massimo Falconi
Topics & Concepts
PandemicMedicineOutbreakRadionuclide therapyNeuroendocrine tumorsCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Health careInternal medicineFamily medicineIntensive care medicineDiseasePathologyInfectious disease (medical specialty)Economic growthEconomicsCOVID-19 and healthcare impactsNeuroendocrine Tumor Research AdvancesCOVID-19 and Mental Health